Fulgent Genetics (FLGT) Shares Outstanding (Diluted Average) (2016 - 2026)
Fulgent Genetics' Shares Outstanding (Diluted Average) history spans 11 years, with the latest figure at $30.9 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.16% to $30.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $30.9 million, a 0.16% change, with the full-year FY2022 number at $31.0 million, changed 0.04% from a year prior.
- Shares Outstanding (Diluted Average) hit $30.9 million in Q1 2026 for Fulgent Genetics, up from $30.7 million in the prior quarter.
- Over the last five years, Shares Outstanding (Diluted Average) for FLGT hit a ceiling of $31.2 million in Q1 2022 and a floor of $29.5 million in Q1 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $30.5 million across 5 years, with a median of $30.6 million in 2025.
- Biggest five-year swings in Shares Outstanding (Diluted Average): decreased 5.45% in 2023 and later increased 3.57% in 2025.
- Tracing FLGT's Shares Outstanding (Diluted Average) over 5 years: stood at $31.0 million in 2022, then fell by 3.07% to $30.0 million in 2023, then grew by 0.27% to $30.1 million in 2024, then rose by 2.04% to $30.7 million in 2025, then grew by 0.56% to $30.9 million in 2026.
- Business Quant data shows Shares Outstanding (Diluted Average) for FLGT at $30.9 million in Q1 2026, $30.7 million in Q3 2025, and $30.5 million in Q2 2025.